Back to Search
CLAUDIO ANASETTI, MD
MD
Medical Oncology Physician
NPI: 1871522995Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME92747(FL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME92747(FL)
Research & Publications (20)
What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?
PMID 19041609·Best Pract Res Clin Haematol·2008
6-review
To ablate or not to ablate? HSCs in the T cell driver's seat.
PMID 17273553·J Clin Invest·2007
7-preclinical
Are matched unrelated donor transplants justified for AML in CR1?
PMID 16516129·Best Pract Res Clin Haematol·2006
6-review
Advances in the prevention of graft-versus-host disease after hematopoietic cell transplantation.
PMID 15201691·Transplantation·2004
6-review
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
PMID 19543327·Bone Marrow Transplant·2010
8-other
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.
PMID 19671874·Clin Cancer Res·2009
8-other
Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
PMID 19539221·Biol Blood Marrow Transplant·2009
8-other
Infliximab for managing steroid-refractory acute graft-versus-host disease.
PMID 19660725·Biol Blood Marrow Transplant·2009
8-other
Quality of life after allogeneic hematopoietic cell transplantation.
PMID 19336756·Blood·2009
4-observational
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
PMID 19450760·Biol Blood Marrow Transplant·2009
8-other
Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.
PMID 19203727·Biol Blood Marrow Transplant·2009
8-other
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
PMID 19059878·Blood·2009
4-observational
Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death.
PMID 19429865·Blood·2009
4-observational
CD28 controls differentiation of regulatory T cells from naive CD4 T cells.
PMID 18684917·J Immunol·2008
4-observational
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
PMID 18541193·Biol Blood Marrow Transplant·2008
8-other
Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.
PMID 18209050·J Immunol·2008
8-other
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
PMID 18981462·J Clin Oncol·2008
4-observational
State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
PMID 18158954·Biol Blood Marrow Transplant·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR
TAMPA, FL 33612 - Phone
- (813) 745-2720
Quick Facts
- NPI
- 1871522995
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile